These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 34884328)
1. Managing the Unpredictable: Mechanistic Analysis and Clinical Recommendations for Lamotrigine Treatment after Bariatric Surgery. Porat D; Azran C; Kais H; Dahan A J Clin Med; 2021 Nov; 10(23):. PubMed ID: 34884328 [TBL] [Abstract][Full Text] [Related]
2. Lamotrigine therapy in patients after bariatric surgery: Potentially hampered solubility and dissolution. Porat D; Azran C; Mualem Y; Vainer E; Gibori R; Vaynshtein J; Dukhno O; Dahan A Int J Pharm; 2022 Jan; 612():121298. PubMed ID: 34793937 [TBL] [Abstract][Full Text] [Related]
3. Antiallergic Treatment of Bariatric Patients: Potentially Hampered Solubility/Dissolution and Bioavailability of Loratadine, but Not Desloratadine, Post-Bariatric Surgery. Porat D; Dukhno O; Vainer E; Cvijić S; Dahan A Mol Pharm; 2022 Aug; 19(8):2922-2936. PubMed ID: 35759355 [TBL] [Abstract][Full Text] [Related]
4. A mechanistic pharmacokinetic model to assess modified oral drug bioavailability post bariatric surgery in morbidly obese patients: interplay between CYP3A gut wall metabolism, permeability and dissolution. Darwich AS; Pade D; Ammori BJ; Jamei M; Ashcroft DM; Rostami-Hodjegan A J Pharm Pharmacol; 2012 Jul; 64(7):1008-24. PubMed ID: 22686346 [TBL] [Abstract][Full Text] [Related]
5. Stomach pH before vs. after different bariatric surgery procedures: Clinical implications for drug delivery. Porat D; Vaynshtein J; Gibori R; Avramoff O; Shaked G; Dukhno O; Czeiger D; Sebbag G; Dahan A Eur J Pharm Biopharm; 2021 Mar; 160():152-157. PubMed ID: 33524534 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics, toxicology and safety of lamotrigine in epilepsy. Biton V Expert Opin Drug Metab Toxicol; 2006 Dec; 2(6):1009-18. PubMed ID: 17125413 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of lamotrigine in children in the absence of other antiepileptic drugs. Chen C; Casale EJ; Duncan B; Culverhouse EH; Gilman J Pharmacotherapy; 1999 Apr; 19(4):437-41. PubMed ID: 10212015 [TBL] [Abstract][Full Text] [Related]
10. RYGB and Drug Disposition: How to Do Better? Analysis of Pharmacokinetic Studies and Recommendations for Clinical Practice. Hachon L; Declèves X; Faucher P; Carette C; Lloret-Linares C Obes Surg; 2017 Apr; 27(4):1076-1090. PubMed ID: 28124236 [TBL] [Abstract][Full Text] [Related]
11. Trends in oral drug bioavailability following bariatric surgery: examining the variable extent of impact on exposure of different drug classes. Darwich AS; Henderson K; Burgin A; Ward N; Whittam J; Ammori BJ; Ashcroft DM; Rostami-Hodjegan A Br J Clin Pharmacol; 2012 Nov; 74(5):774-87. PubMed ID: 22463107 [TBL] [Abstract][Full Text] [Related]
12. Medication and nutrient administration considerations after bariatric surgery. Miller AD; Smith KM Am J Health Syst Pharm; 2006 Oct; 63(19):1852-7. PubMed ID: 16990631 [TBL] [Abstract][Full Text] [Related]
13. Dronedarone (a multichannel blocker) enhances the anticonvulsant potency of lamotrigine, but not that of lacosamide, pregabalin and topiramate in the tonic-clonic seizure model in mice. Sawicka KM; Florek-Łuszczki M; Wawryniuk A; Daniluk J; Wróblewska-Łuczka P; Chmielewski J; Karwan S; Łuszczki JJ Epilepsy Res; 2019 Aug; 154():62-68. PubMed ID: 31059963 [TBL] [Abstract][Full Text] [Related]
14. Dosing Recommendations Based on Population Pharmacokinetics of Lamotrigine in Mexican Adult Patients With Epilepsy. Chávez-Castillo CE; Medellín-Garibay SE; Milán-Segovia RDC; Rodríguez-Leyva I; Romano-Moreno S J Pharm Sci; 2020 Sep; 109(9):2902-2908. PubMed ID: 32534880 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of lamotrigine and its metabolite N-2-glucuronide: Influence of polymorphism of UDP-glucuronosyltransferases and drug transporters. Milosheska D; Lorber B; Vovk T; Kastelic M; Dolžan V; Grabnar I Br J Clin Pharmacol; 2016 Aug; 82(2):399-411. PubMed ID: 27096250 [TBL] [Abstract][Full Text] [Related]
16. Properties of antiepileptic drugs in the treatment of idiopathic generalized epilepsies. Patsalos PN Epilepsia; 2005; 46 Suppl 9():140-8. PubMed ID: 16302888 [TBL] [Abstract][Full Text] [Related]
17. Clinicians' prescribing practices for bariatric surgery patients: is there an issue? Guedes BL; Montanha MC; Teixeira JJ; Diniz A; Silva SR; Previdelli I; Nasser D; Yamada SS; Kimura E J Clin Pharm Ther; 2015 Feb; 40(1):104-9. PubMed ID: 25302403 [TBL] [Abstract][Full Text] [Related]
18. Influence of concurrent antiepileptic medication on the pharmacokinetics of lamotrigine as add-on therapy in epileptic children. Vauzelle-Kervroëdan F; Rey E; Cieuta C; Pariente-Khayat A; Pons G; d'Athis P; Bidault R; Dulac O; Olive G Br J Clin Pharmacol; 1996 Apr; 41(4):325-30. PubMed ID: 8730979 [TBL] [Abstract][Full Text] [Related]
19. Oral drug therapy following bariatric surgery: an overview of fundamentals, literature and clinical recommendations. Azran C; Wolk O; Zur M; Fine-Shamir N; Shaked G; Czeiger D; Sebbag G; Kister O; Langguth P; Dahan A Obes Rev; 2016 Nov; 17(11):1050-1066. PubMed ID: 27335140 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic interactions between lamotrigine and other antiepileptic drugs in children with intractable epilepsy. Eriksson AS; Hoppu K; Nergårdh A; Boreus L Epilepsia; 1996 Aug; 37(8):769-73. PubMed ID: 8764817 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]